Status:
COMPLETED
Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)
Lead Sponsor:
Organon and Co
Conditions:
Migraine
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.
Eligibility Criteria
Inclusion
- Female patient at least 18 years old
- Patient has menses approximately monthly
- Patient has at least a 6 month history of migraine and at least a 6 month history of menstrual migraine
Exclusion
- Pregnant and/or nursing mother
- Cardiovascular disease
- Uncontrolled hypertension
Key Trial Info
Start Date :
May 27 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 23 2006
Estimated Enrollment :
393 Patients enrolled
Trial Details
Trial ID
NCT00111722
Start Date
May 27 2005
End Date
February 23 2006
Last Update
August 14 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.